Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Vaccines for pandemic influenza: summary of recent clinical trials.

Keitel WA, Atmar RL.

Curr Top Microbiol Immunol. 2009;333:431-51. doi: 10.1007/978-3-540-92165-3_21. Review.

PMID:
19768418
2.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

3.

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17.

4.

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.

Forrest HL, Khalenkov AM, Govorkova EA, Kim JK, Del Giudice G, Webster RG.

Vaccine. 2009 Jun 24;27(31):4187-95. doi: 10.1016/j.vaccine.2009.04.050. Epub 2009 May 9.

5.

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, Kuhne M, Höschler K, Saville M, Vogel FR, Barclay W, Donatelli I, Zambon M, Wood J, Haaheim LR.

Vaccine. 2009 Mar 18;27(13):1889-97. doi: 10.1016/j.vaccine.2009.01.116. Epub 2009 Feb 2.

PMID:
19368768
6.

Antibody recognition of a highly conserved influenza virus epitope.

Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA.

Science. 2009 Apr 10;324(5924):246-51. doi: 10.1126/science.1171491. Epub 2009 Feb 26.

7.

The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.

Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, Miller LH, Martin LB, Pierce SK.

J Immunol. 2009 Mar 1;182(5):3318-26. doi: 10.4049/jimmunol.0803596.

8.

Correlates of protection: novel generations of influenza vaccines.

Rimmelzwaan GF, McElhaney JE.

Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. Review.

PMID:
19230158
9.

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K.

J Infect Dis. 2009 Mar 1;199(5):711-6. doi: 10.1086/596558.

10.

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Cheng X, Eisenbraun M, Xu Q, Zhou H, Kulkarni D, Subbarao K, Kemble G, Jin H.

PLoS One. 2009;4(2):e4436. doi: 10.1371/journal.pone.0004436. Epub 2009 Feb 11.

11.

Human immune memory to yellow fever and smallpox vaccination.

Wrammert J, Miller J, Akondy R, Ahmed R.

J Clin Immunol. 2009 Mar;29(2):151-7. doi: 10.1007/s10875-008-9267-3. Epub 2008 Dec 4.

PMID:
19052852
12.

Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells.

Kyu SY, Kobie J, Yang H, Zand MS, Topham DJ, Quataert SA, Sanz I, Lee FE.

J Immunol Methods. 2009 Jan 1;340(1):42-7. doi: 10.1016/j.jim.2008.09.025. Epub 2008 Nov 6.

13.

In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

Co MD, Orphin L, Cruz J, Pazoles P, Green KM, Potts J, Leporati AM, Babon JA, Evans JE, Ennis FA, Terajima M.

Vaccine. 2009 Jan 7;27(2):319-27. doi: 10.1016/j.vaccine.2008.09.092. Epub 2008 Oct 31.

14.

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T.

J Clin Invest. 2008 Oct;118(10):3478-90. doi: 10.1172/JCI32460. Erratum in: J Clin Invest. 2012 Nov 1;122(11):4301.

15.

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.

J Infect Dis. 2008 Sep 1;198(5):635-41. doi: 10.1086/590916.

PMID:
18694338
16.

Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.

Terajima M, Cruz J, Leporati AM, Orphin L, Babon JA, Co MD, Pazoles P, Jameson J, Ennis FA.

J Virol. 2008 Sep;82(18):9283-7. doi: 10.1128/JVI.01047-08. Epub 2008 Jul 9.

17.

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

Eichelberger M, Golding H, Hess M, Weir J, Subbarao K, Luke CJ, Friede M, Wood D.

Vaccine. 2008 Aug 12;26(34):4299-303. doi: 10.1016/j.vaccine.2008.06.012. Epub 2008 Jun 26.

PMID:
18582523
18.

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC.

Nature. 2008 May 29;453(7195):667-71. doi: 10.1038/nature06890. Epub 2008 Apr 30.

19.

Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Co MD, Orphin L, Cruz J, Pazoles P, Rothman AL, Ennis FA, Terajima M.

Vaccine. 2008 Apr 7;26(16):1990-8. doi: 10.1016/j.vaccine.2008.02.024. Epub 2008 Feb 26.

20.

Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.

He XS, Holmes TH, Mahmood K, Kemble GW, Dekker CL, Arvin AM, Greenberg HB.

J Infect Dis. 2008 Mar 15;197(6):803-11. doi: 10.1086/528804.

PMID:
18279048

Supplemental Content

Support Center